Benzathine penicillin G market outlooks and analysis by application, mode of injection, end user -forecast till 2030. The antibody is used to treat different bacterial infections. Rheumatic fever and associated heart issues are also treated with it. Due to the increased incidence of several bacterial illnesses like gonorrhea, meningitis, and others, the market for benzathine penicillin G is anticipated to experience phenomenal growth. Infectious diseases, respiratory infections brought on by bacterial infections, a shift to a sedentary lifestyle, rheumatic heart ailments, and other important causes all contribute to the market’s expansion.
According to the World Heart Federation, 3 million people get affected with the rheumatic heart disease every year. Such an incidence of rheumatic heart disease and meningitis supports market growth.
However, throughout the anticipated period, issues like a lack of knowledge of the treatment and the adverse effects of therapies are anticipated to restrain the expansion of the Benzathine Penicillin G market.
Some of the key players in the global Benzathine Penicillin G market are Abcam plc, Pfizer Inc, Alembic IT Department, ECPlaza Network Inc, Sandoz International GmbH, Merck KGaA, Triveni Interchem Private Limited, CSC Pharmaceuticals, and others.
The global Benzathine Penicillin G market share is segmented on the basis of application, mode of injection, and end user.
On the basis of application, is segmented into bacterial infections and sexually transmitted infection (STI) syphilis therapy. Bacterial infections are further segmented into Bejel, diphtheria, and rheumatic fever.
On the basis of mode of injection, the market is segmented into intravenous and intramuscular injection.
On the basis of end user, the global Benzathine Penicillin G market is segmented into hospitals and clinics, diagnostic centers, ambulatory surgical centers, research centers, and others.
The Americas is the largest in the market owing to the increasing prevalence of rheumatic heart disorders and growing healthcare expenditure. According to the National Meningitis Association, every year approximately 600 to 1000 people are affected by the meningococcal disease in the US. Such a high incidence rate of meningococcal disease drives the market growth in this region.
Europe (UK, Belgium, France, and Netherlands) is expected to be the second largest Benzathine Penicillin G market during the forecast period. The increasing occurrence of sexually infective diseases positively drives the market in this region. According to the European Centre for Disease Prevention and Control, it is estimated that every year approximately 146 million cases of sexually transmitted infections are found worldwide.
Asia-Pacific was projected to be the fastest growing region for the global Benzathine Penicillin G market. The market is expected to witness growth owing to the increasing awareness about the treatment and increasing research and development centers in this region.
The Middle East and Africa accounts for the lowest share due to lack of availability of well-trained healthcare professionals and low per capita income. However, the rising number of hospitals and healthcare services in the community are expected to support the market. In the region, some developing countries are rising their investments in research and development which is anticipated to contribute to the growth of the market.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)